The expansion in demand is largely attributed to the benefits of minimizing complications due to larger surgical sites and over distraction of involved nerves.

In addition, time in the operating room and reducing postoperative pain for patients.

According to Trinity Orthopedics, the interbody fusion market in the US is likely to remain in the low single digits until 2019. The sub-segment of expandable devices will see compound annual growth rates approaching 30%.

Trinity Orthopedics CEO and founder Dr James F Marino noted the company believes that it has a very strong proprietary position in this area of intense industry interest.

Dr Marino, the former founder of NuVasive, will continue to pursue technology that assists in restoring and maintaining the natural biomechanics of the spine, while ensuring patient safety and outcomes.

Trinity Orthopedics develops products including the ReStor posterior fixation system and the Corex minimally invasive autograft bone harvester.